Saba Capital (NYSE: ECAT) trims BlackRock ESG Capital stake with share sale
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On February 2, 2026, it sold 178,239 common shares at $15.55 per share in an open-market transaction coded as a sale.
After this transaction, Saba Capital Management, L.P. beneficially owned 24,968,217 ECAT common shares, held indirectly. The filing reflects an adjustment to an existing large position rather than an initial purchase or complete exit.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 178,239 shares ($2,771,616)
Net Sell
1 txn
Insider
Saba Capital Management, L.P.
Role
10% Owner
Sold
178,239 shs ($2.77M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 178,239 | $15.55 | $2.77M |
Holdings After Transaction:
Common Stock — 24,968,217 shares (Indirect, -)
Footnotes (1)
FAQ
What did Saba Capital Management report in its latest Form 4 for ECAT?
Saba Capital Management, L.P. reported selling 178,239 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock at $15.55 per share, and now beneficially owns 24,968,217 ECAT shares indirectly following this transaction.
What is Saba Capital Management’s relationship to BlackRock ESG Capital Allocation Term Trust (ECAT)?
Saba Capital Management, L.P. is listed as a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT). This status indicates it beneficially owns at least 10% of the trust’s common shares, requiring ongoing Section 16 ownership reporting.
Was the ECAT transaction reported by Saba Capital derivative or non-derivative?
The reported ECAT transaction by Saba Capital Management, L.P. was a non-derivative transaction in common stock. No derivative securities such as options or warrants were listed in the Form 4 tables for this particular filing.